Gracell Biotechnologies I...

NASDAQ: GRCL · Real-Time Price · USD
10.25
0.01 (0.05%)
At close: Feb 21, 2024, 10:00 PM

Gracell Biotechnologies Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.45B 1.83B
Short-Term Investments
3.56M 3.62M
Long-Term Investments
n/a n/a
Other Long-Term Assets
15.85M 1.62M
Receivables
n/a 0.00
Inventory
-26.33M 8.7M
Other Current Assets
37.55M 46.04M
Total Current Assets
1.5B 1.89B
Property-Plant & Equipment
144.67M 173.44M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
160.52M 175.06M
Total Assets
1.66B 2.06B
Account Payables
n/a 62.46M
Deferred Revenue
2.9M 2.9M
Short-Term Debt
129.99M 86M
Other Current Liabilities
90.65M 3.76M
Total Current Liabilities
220.64M 155.12M
Long-Term Debt
52.99M 69.18M
Other Long-Term Liabilities
6.88M 8.46M
Total Long-Term Liabilities
59.87M 77.64M
Total Liabilities
280.51M 232.77M
Total Debt
182.98M 155.18M
Common Stock
223K 223K
Retained Earnings
-1.63B -1.02B
Comprehensive Income
73.53M -57.94M
Shareholders Equity
1.38B 1.83B
Total Investments
3.56M 3.62M